Technology News and Research

RSS

Stem cell research could lead to new treatment strategies for motor neuron disease

The Motor Neurone Disease Association is funding its first ever stem cell research programme to help unlock the secrets of this fatal, neurological condition.

24 May 2010

Feed the Future Guide for Obama administration's food security plan released

The "full details of how the money will be spent" has not yet been released, but the guide said the initiative would aim to increase "access to products such as fertilisers and new technology, including agriculture biotechnology," the Financial Times reports.

24 May 2010

Today's OpEds: Wyden on bipartisanship health reform; How to spend prevention funds; CLASS Act

I still think I had a pretty good idea for health reform — despite its rejection by significant Democratic and Republican leaders — but so did Bob Bennett. I was on the Senate floor three years ago when Bob walked across the center aisle to tell me he was willing to work with me on health reform (Sen. Ron Wyden, 5/21).

21 May 2010

Research aims to describe women's experience of living with MS

The women who I asked would like to have time and opportunity to express grief and vulnerability in contact with health services. They also expect a response based on their individual situation and needs, "said Malin Olsson, Ph.D. at Luleå University of Technology.

21 May 2010

Axis Three announces availability of new XS-400 scanner for face, breast and body procedures

Axis Three, the leader and pioneer of 3D surgical simulation tools for aesthetic consultations, today announced the availability of its new XS-400 scanner, a turnkey system designed to address face, breast, and body procedures. The only 4-position 3D scanner on the market, the elegant XS-400 captures anatomically-accurate, 3D images of a patient's face or body, and serves as a vehicle to extend Axis Three's unrivaled simulation platform to an even broader range of cosmetic procedures.

21 May 2010

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

Competitive Technologies, Inc. today announced the issuance of an abstract from a study which has shown the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy using CTT's Calmare Pain Therapy Treatment.

21 May 2010

PLC Systems' RenalGuard to be showcased at EuroPCR 2010

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.

21 May 2010

New England Peptide launches NEPTune line of custom proteomics reagents

New England Peptide (NEP) today introduced NEPTune TM, a new proprietary line of custom proteomics reagents to help its customers to quickly and inexpensively maximize biomarker assay development and produce consistent results.

21 May 2010

Vitacost.com announces expansion of operations in North Carolina

Vitacost.com, Inc., a leading online retailer and direct marketer of health and wellness products, today announced the groundbreaking for the expansion of its east coast manufacturing and distribution facility in Lexington, North Carolina.

21 May 2010

Drug and alcohol experts to take part in T2010 conference

In August 2010, researchers and experts on drugs, alcohol and medicines will take part in the T2010 conference, the tri-annual meeting of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS). This year's meeting is being hosted by the Norwegian Institute of Public Health.

21 May 2010

New drug testing technique is safe and effective

A new study from the Swedish medical university Karolinska Institutet presents a new technique that makes drug testing possible through exhaled air for the first time.

21 May 2010

Pluristem to highlight potential of PLX-PAD cell therapy for critical limb ischemia at 16th ISCT

Pluristem Therapeutics Inc. today announced that its off-the-shelf placenta-derived cell therapies will be the focus of presentations at upcoming investor and medical conferences.

21 May 2010

Leading cardiologist uses new imaging system

LightLab Imaging, Inc. announced today that Good Morning America featured Dr. Marco Costa, a leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University Hospitals, Case Western Reserve University, using the newest imaging technology available to hospitals in the United States – Optical Coherence Tomography.

21 May 2010

Nektar Therapeutics to present data of NKTR-102 Phase 2 clinical trial in ovarian cancer at 46th ASCO

Nektar Therapeutics today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).

21 May 2010

Datasource Mobility to illustrate new healthcare product from Panasonic

DataSource Mobility is pleased to announce that it is one of a select group of Toughbook Preferred Partners to sell the Toughbook C1—the newest healthcare specific product from Panasonic®, the world leader in rugged mobile computers.

From PHC Europe B.V. 21 May 2010

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Sorrento Therapeutics, Inc. today announced that it has received an Advanced Technology Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus infections, including methicillin-resistant S. aureus, by disrupting quorum sensing, a bacterial communication process essential to virulence.

21 May 2010

New synthesized genome may lead to advances in health and biotechnology

The successful construction of a synthesized genome could enable new research and development of human therapies, biofuels, and biobased chemicals from renewable resources.

21 May 2010

'Teachable moments' can reduce cancer risk in children of parents with mutations in tumor suppressor genes

Parents found to be carriers of a mutated form of the tumor suppressor genes known as BRCA1 and BRCA2 do not always share these test results with their children, but they may choose to discuss related information important to their own health with them. That is the result of a study conducted by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues, whose findings suggest that those parents are using the discovery of their mutation status as an opportunity for a "teachable moment" in educating their offspring about cancer risk reduction.

21 May 2010

Top scientists to share latest research on autism at IMFAR 2010

Autism Speaks, the world's largest autism science and advocacy organization, is a major sponsor and scientific participant in the 2010 International Meeting for Autism Research (IMFAR).

21 May 2010

Pressure treated playground structures are not harmful for children: Study

Pressure treated wooden playground structures do not live up to the bad reputation they have earned as being harmful to children, according to the findings of a new University of Alberta study.

21 May 2010